Skip to content
Dendreon
  • News
  • Contact Us
  • About
  • Science and Services
    • Cellular Therapy Manufacturing
    • Provenge Immunotherapy
  • Publications
  • Careers
News Low Disease Burden In MCRPC Improves Sipuleucel-T Survival Benefit
December 5, 2019

Low Disease Burden In MCRPC Improves Sipuleucel-T Survival Benefit

  • News Type: Media Coverage
Read More
LinkedInShareTweet
Dendreon
© Dendreon Pharmaceuticals LLC. All Rights Reserved. 2026.
  • Privacy Policy
  • Legal Notice
  • Site Map
  • Linkedin
  • Facebook
  • Twitter
  • YouTube